Patents by Inventor David Emanuel

David Emanuel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240018203
    Abstract: The present disclosure provides zinc finger fusion proteins that inhibit expression of alpha-synuclein in the nervous system, and methods of using the proteins to treat Parkinsons disease, Lewy body dementia, multiple system atrophy, Alzheimers disease, and other neurodegenerative diseases.
    Type: Application
    Filed: October 1, 2021
    Publication date: January 18, 2024
    Applicant: Sangamo Therapeutics, Inc.
    Inventors: Asa Hatami, Bryan Zeitler, Lei Zhang, David Emanuel Paschon
  • Publication number: 20230225800
    Abstract: In some embodiments, there are provided systems, devices, components, and corresponding methods configured to permit navigation and/or positioning of an intra-cardiac electrophysiological (EP) mapping basket or other EP mapping structure of an EP mapping catheter inside or near an atrium or other heart chamber of a patient's heart using biosignals or intra-cardiac signals. In one embodiment, QRS complexes are extracted or isolated from intra-cardiac signals sensed by electrodes mounted on the EP mapping basket. Using the QRS complexes and a statistical shape or other model of the EP mapping basket or other type of EP mapping structure, one or more computing devices then determine the locations of the electrodes inside or near the patient's atrium that are associated with each isolated or extracted QRS complex, and thereby permit accurate navigation within the heart and/or processing of data acquired using the EP mapping basket or other EP mapping structure.
    Type: Application
    Filed: March 23, 2023
    Publication date: July 20, 2023
    Inventors: Alessa Tabea Grund, Stefan Marcel Denner, David Emanuel Luksic, Philip Haeusser, Peter Ruppersberg, Kostiantyn Serhiyovich Ahapov
  • Patent number: 11672465
    Abstract: Electrographic flow mapping (EGF mapping) is a technique used for aiding catheter ablation when treating atrial fibrillation. Visualizing EGF fields during a cardiac catherization and ablation procedure is an important and necessary part of conducting the procedure. Several different visualization methods are described and disclosed herein that may be employed to visualize EGF fields and maps, including quiver plots, streamline plots, particle plots, particle trail plots, moving particle plots, and moving and fading particle plots.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: June 13, 2023
    Assignee: Ablacon Inc.
    Inventors: David Emanuel Lukŝic, Philip Haeusser, Peter Ruppersberg
  • Publication number: 20220386924
    Abstract: In some embodiments, there are provided systems, devices, components, and corresponding methods configured to permit navigation and or positioning of an intra-cardiac electrophysiological (EP) mapping basket of an EP mapping catheter inside or near an atrium or other heart chamber of a patient's heart using biosignals or intra-cardiac signals. In one embodiment, QRS complexes are extracted or isolated from intra-cardiac signals sensed by electrodes mounted on the EP mapping basket. Using the QRS complexes, one or more computing devices then determine the locations of the electrodes inside or near the patient's atrium that are associated with each isolated or extracted QRS complex. The one or more computing devices can also be used to determine changes in the three-dimensional locations and orientations of the basket and the electrodes thereof as the basket is moved around, in, or near the patient's atrium, heart chamber, or other portion of the patient's heart.
    Type: Application
    Filed: July 12, 2022
    Publication date: December 8, 2022
    Inventors: Stefan Marcel Denner, Philip Haeusser, Peter Ruppersberg, David Emanuel Luksic, Alessa Tabea Grund
  • Publication number: 20220324928
    Abstract: The present disclosure provides zinc finger fusion proteins that inhibit expression of alpha-synuclein in the nervous system, and methods of using the proteins to treat Parkinson's disease, Lewy body dementia, multiple system atrophy, Alzheimer's disease, and other neurodegenerative diseases.
    Type: Application
    Filed: October 2, 2020
    Publication date: October 13, 2022
    Applicant: Sangamo Therapeutics, Inc.
    Inventors: Asa Hatami, Bryan Zeitler, Lei Zhang, David Emanuel Paschon
  • Publication number: 20220297386
    Abstract: The Continuous Sealing Machine for two plastic films performs continuous sealing of two films, a tubular with gussets and a plastic film, folds the gussets of the new compartment and as a result two compartment rolls are obtained, both compartments with gussets. This high performance machine provides the means for a modernization of the plastics industry. It is a machine on a main structure consisting of: Unwinders Outriggers Edge aligners Pulling roller systems Antistatic bars Antistatic bars Special device Motors with gearbox coupled to gearbox Automatic brakes Electromagnetic clutches continuous sealers Bellows former Camshaft sealers Front puller roll pitch motor Winding rods, foil positioning systems. It is part of the plastic industry machines together with extruders, printers, sealers, trimmers, raw material mixers and stencil assembly machines.
    Type: Application
    Filed: May 7, 2020
    Publication date: September 22, 2022
    Inventors: Maria Immaculada Char Abdala, David Emanuel Manotas Char
  • Publication number: 20210282693
    Abstract: Disclosed are various examples and embodiments of systems, devices, components and methods configured to detect the locations of sources of cardiac rhythm disorders in a patient's heart, and then to generate an estimate or probability of the patient being free from atrial fibrillation. The various embodiments employ at least one computing device to process a plurality of electrogram surfaces through time to generate at least one electrographical flow (EGF) map, representation, pattern, or data set, and then process the at least one EGF map, representation, pattern, or data set to determine at least two of source activity levels, flow angle variability (FAV) levels, and active fractionation (AFR) levels corresponding thereto. On the basis of a combination of the determined at least two of source activity levels, FAV levels, and AFR levels, an electrographical volatility index (EVI) score or metric representative of the estimate or probability of the patient being free from AF is generated.
    Type: Application
    Filed: May 26, 2021
    Publication date: September 16, 2021
    Inventors: Peter Ruppersberg, Philip Haeusser, Melissa Huang Szu-Min Kong, David Emanuel Luksic, Kostiantyn Serhiyovich Ahapov
  • Publication number: 20210000369
    Abstract: Electrographic flow mapping (EGF mapping) is a technique used for aiding catheter ablation when treating atrial fibrillation. Visualizing EGF fields during a cardiac catherization and ablation procedure is an important and necessary part of conducting the procedure. Several different visualization methods are described and disclosed herein that may be employed to visualize EGF fields and maps, including quiver plots, streamline plots, particle plots, particle trail plots, moving particle plots, and moving and fading particle plots.
    Type: Application
    Filed: July 1, 2020
    Publication date: January 7, 2021
    Inventors: David Emanuel Luksic, Philip Haeusser, Peter Ruppersberg
  • Publication number: 20140244294
    Abstract: A server includes a processor and a memory connected to the processor. The memory stores instructions executed by the processor. The instructions receive medical event data from a mobile device, an identification for a patient and mobile device parameters. The identification for the patient is matched with medical records and response rules for the patient. The response rules are executed to selectively notify a civic responder and an incident management module. Communications with the patient and specified emergency contacts associated with the patient are coordinated.
    Type: Application
    Filed: February 25, 2013
    Publication date: August 28, 2014
    Applicant: Medlert, Inc.
    Inventors: David Emanuel, Ernest W. Semerda
  • Publication number: 20060184013
    Abstract: A method and apparatus for determining position and rotational orientation of an object within a predetermined area is disclosed. Position markers, encoded with their identity, are viewed with a camera, images are captured and processed, and the position and rotational orientation of the object are calculated. Three embodiments are disclosed; the first having a camera mounted on the movable object while position markers bearing linear bar codes are fixed in location, the second having a camera mounted on the movable object while position markers bearing two-dimensional bar codes are fixed in location, and the third having a position marker of either type affixed to the object while the camera is fixed in location.
    Type: Application
    Filed: December 3, 2005
    Publication date: August 17, 2006
    Applicant: Sky-Trax Incorporated
    Inventors: David Emanuel, Larry Mahan, Richard Ungerbuehler
  • Publication number: 20040266809
    Abstract: Multiple myeloma can be treated by administration of irinotecan combined with revimid. The present invention includes methods of treating multiple myeloma by administering the combination of irinotecan and revimid, as well as pharmaceutical kits.
    Type: Application
    Filed: May 18, 2004
    Publication date: December 30, 2004
    Inventors: David Emanuel, Sumant Ramachandra
  • Publication number: 20040266704
    Abstract: The present invention relates to a method for treating locally advanced or metastatic breast cancer in a patient who demonstrated failure of prior treatment with an anthracycline, a taxane and a fluoropyrimidine, which comprises administering a therapeutically effective amount of irinotecan.
    Type: Application
    Filed: April 26, 2004
    Publication date: December 30, 2004
    Inventors: Langdon L. Miller, David Emanuel, James Patrick McGovren, Larry J. Schaaf, Sumant Ramachandra
  • Patent number: 5989135
    Abstract: The golf ball of the present invention has a white core which has a bright, white outer surface and a relatively thin, translucent cover composed of SURLYN.RTM. having a thickness of about 0.06 inches or less. The translucent SURLYN.RTM. cover contains between 6% and 12% by weight photostorage material, of the type having components such as aluminum oxide, strontium oxide, calcium oxide, europium oxide and boron oxide. A brightly colored fluorescent dye at a concentration between 0.01% and 0.04% by weight can also be added to a SURLYN.RTM. cover material to produce a golf ball of the present invention that is brightly colored. When the golf ball of the present invention has no fluorescent dye in its cover, it is substantially white in appearance, is visible in daylight and after being charged by exposure to light, emits a long lasting bright glow of light for high visibility in the dark.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: November 23, 1999
    Assignee: Night & Day Golf, Inc.
    Inventor: David Emanuel Welch
  • Patent number: 3967554
    Abstract: The safety and arming device timer is a small, inexpensive, highly accurate lectronic time delay compatible with the existing electronics for a safety and arming device for a guided projectile to provide for safe separation of the projectile from the gun.
    Type: Grant
    Filed: July 21, 1975
    Date of Patent: July 6, 1976
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventor: David Emanuel Troyer, Jr.